Page 12 - Flipbook
P. 12
mCSPC - Treatment
ADT via either LHRH agonists or antagonists/surgical castration
Systemic treatment intensification beyond ADT (based on Level I
evidence)
◦ Novel hormonal agents (Abiraterone, Enzalutamide, Apalutamide)
◦ Chemotherapy (docetaxel)
